Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Morgan Stanley Healthcare Conference
September 09, 2010 3:04 PM
Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the 2010 Morgan Stanley Global Healthcare Unplugged Conference will be webcast and may be accessed at www.hgsi.com.
A member of Human Genome Sciences’ senior management team will present a corporate overview on Monday, September 13, 2010, at 11:30 AM Eastern. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.
About Human Genome Sciences
The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.
For more information about HGS, please visit the Company’s web site at www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to medinfo@hgsi.com or by calling HGS at (877) 822-8472.
HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc.
Human Genome Sciences, Inc.
Media Contact:
Jerry Parrott
Vice
President, Corporate Communications
301-315-2777
or
Investor
Contact:
Claudine Prowse, Ph.D.
Executive Director,
Investor Relations
301-315-1785
or
Peter Vozzo
Senior
Director, Investor Relations
301-251-6003
